NV
Novo Integrated Sciences, Inc.
NVOS · OTC
$0.00 +0.00% (+$0.00)
1M +550.00%
Market Cap $76.9K
P/E Ratio -
Div. Yield -
ROE 91.57%
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/B 0.01x
P/S 0.01x
PEG N/A
Growth
61 /100
Stable Book val. growth 30.24%
Rev. growth 12.63%
FCF growth N/A
Profitability
17 /100
Weak FCF margin 38.17%
Op. margin 62.54%
Gross margin 43.20%
Quality
5 /100
Poor Asset turnover 0.41x
ROA 50.30%
ROIC 40.13%
Debt
46 /100
Moderate Current ratio 0.37x
Int. coverage -1.23x
Debt/Equity 0.32x
Stability
26 /100
Unstable Profitable years 0
EPS volatility 339.72%
Beta 5.83x
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na NVOS
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Robert Mattacchione
Employees
115
Headquarters
Bellevue